Search In this Thesis
   Search In this Thesis  
العنوان
Use of Sildenafil Citrate (respatio ®) in management of mild pre-eclampsia:
المؤلف
Mohamed, Ahmed Tantawy Ahmed.
هيئة الاعداد
باحث / أحمد طنطاوي أحمد محمد
مشرف / أحمد رضا العدوي
مشرف / ريهام رفعت طه
مشرف / محمد أحمد محمد
الموضوع
Hypertension in pregnancy. Sildenafil.
تاريخ النشر
2022.
عدد الصفحات
115 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض النساء والتوليد
تاريخ الإجازة
1/1/2022
مكان الإجازة
جامعة المنيا - كلية الطب - أمراض النساء والتوليد
الفهرس
Only 14 pages are availabe for public view

from 116

from 116

Abstract

Objective
This test test out using respatio in instances with mild pregnancy induced hypertension useful in being pregnant prolongation thru controling of its advanced to SPE and enhancing mother and baby outcome .
Patients and strategies
In a by tuss, unmarried-nonwatched, fake drug managed trial, 198 lonly conception with moderate pre-fits between 28 and 36 weeks of gestation had been randomized to either use tongue respatio capsules plus or without hypertensive pills. number one final results become prevention of prevalence of maternal and/or neonatal headaches.Results
Use of SC probably amplify the GA at TOP thru 36.2% OR=1.362, P=0.381 .
Time of TOP in the intervention organization ranged from 35 to 38 with mean 37.3±1 wks. even as within the placebo group it ranged from 34 to 38 with imply 37±1.2wk , that was insignificant between the two businesses . P = 0.194 .
Use of SC doubtlessly lower the risk headaches thru forty seven.1% OR=0.529 , p=zero.079 .General huge style of hassle become 30 case 33.Three% in placebo and 15 case 15.2% for the intervention institution with significant p rate zero.057* , SPE was giant excessive in placebo institution 25.24% than in intervention corporation 15.2% .
Apgar score at the beginning five mins turned into appreciably higher inside the intervention institution 7.8±zero.6 , starting from five to 9 than the placebo institution 7.1±1.Three, ranging from 0 to 8 p fee 0.012*. The propose delivery weight modified into significantly higher within the intervention corporation three.1±zero.Three kg vs. 2.Eight±0.Four in placebo group ; P = .027* The need for NICU in the intervention institution have become notably decrease than that in the placebo group 6.1% to 12.1% respectively. The duration of stay in the NICU in days changed into considerably better inside the placebo group than within the intervention organization .There become 2 intrauterine fetal deaths have befell in our have a look at at placebo employer , and one neonatal dying passed off within the placebo group.
Conclusion
Preeclampsia is a commonplace, doubtlessly deadly syndrome and has lengthy time period effects for each the mother and her baby. SC became found to have a pleasant protection and efficacyprofile as an antihypertensive agent in preeclamptic women. We have very well achieved a systematic trial of respatio within the direction of being pregnant. Sildenafil within the escalating dose regimen in step with BMI / divided on 3 doses consistent with day modified into nicely tolerated and normal it’s far safe to apply SC as there was no any extreme destructive maternal aspect results or any increase inside the fee of death, newborn deaths, or congenital abnormal within the neonates.
swallow respatio similarly to other depressor capsules in the conrol of moderate pre‑fits is effective in prolongation of pregnancy, it extended the GA at TOP through 36.2% .And has a higher maternal final results ,it probably decrease the threat headaches by using 47.1%
And has higher fetal final results , boom beginning weight ,and reduce need to NICU admission in preterm shipping , and time of NICU stay.
Recommendation
Our have a look at confirms that respatio is promising remedy of pregnancy induced hypertension , we can use SC for management of MPE with or without antihypertensive tablets, this based on its efficacy in lower maternal arterial blood stress ,and reducing threat of improvement to worry of pregnancy induced hypertension, and enhance fetal outcome.
Side outcomes of respatio are dose based so we need to alter the dose in line with BMI , this is best manner to avoid them.
We advocate to research the use of Respatio in early GA of pregnancy and efficacy on little one and mothers with preceding history of pre eclampsia.
We endorse to do many studies of Respatio in pregnancy induced hypertension in destiny, to verify its efficacy on control of slight pregnancy induced hypertension.